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Abstract: Guajadials C–F (1–4), four sesquiterpenoid-based meroterpenoids with unprecedented skeletons were isolated from the 
leaves of Psidium guajava. Their structures and relative configurations were established by extensive spectroscopic analysis. A 
possible biosynthetic pathway for 1–4 was also proposed. 
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Introduction 
Psidium guajava L. (Myrtaceae) is an evergreen shrub 
grown in tropical and subtropical regions as a food, and is also 
an indigenous medicinal plant used to treat inflammation,  
diabetes, hypertension, wounds, pain, fever, vomiting, and 
diarrhea.1 In recent years, several sesquiterpene-based mero-
terpenoids with unusual skeletons have been discovered from 
the leaves of P. guajava,2 some of which exhibited significant 
biological activities including inhibitory effects on proton  
tyrosine phosphatase 1B (TPT1B)2b and the growth of human 
hepatoma cell (HepG2 and HepG2/ADM).2c,d Plausible  
biosynthetic pathways2a,b,d and biomimetic synthesis2e,3 relative 
to Psidium meroterpenoids had also stimulated considerable 
interest in several laboratories. In continuation of our studies 
on structurally unique and biologically active Psidium mero-
terpenoids, by which two rare meroterpenoids guajadial2a and 
guajadial B2e had previously been discovered, another four 
novel meroterpenoids guajadials C–F (1–4) were isolated from 
the leaves of P. guajava. Herein, we describe the isolation, 
structure elucidation, plausible biosynthetic pathway, and  
cytotoxicity of the new compounds. 
 
Results and Discussion 
Guajadial C (1), obtained as amorphous powder, [α]24D   + 
93.5 (c 0.20, CHCl3). It possessed a molecular formula of 
C30H34O5, as evidenced by high-resolution EI mass spectrum at 
m/z 474.2401 (calcd 474.2406), in combination with the 1H 
and 13C NMR spectra (Table 1), requiring 14 degrees of  
unsaturation. The IR spectrum suggested the presence of  
hydroxyl (3441 cm–1) and conjugated carbonyl (1633 cm–1) in 
1. The UV spectrum (MeOH) of 1 showed the absorptions 
maxima at 278 and 337 (sh) nm. Analysis of the NMR data 
displayed the presence of two chelated phenolic hydroxyls, 
two aldehydes, three methyls, a monosubstituted benzene ring, 
and a hexasubstituted aromatic ring (Table 1). These  
spectroscopic features implied that 1 was a benzyldi-
formylphloroglucinol-coupled sesquiterpenoid.2 
In the HMBC spectrum (Figure 1), cross-peaks from H-1′ to 
C-2′, C-3′, C-7′, C-8′, C-9′, and C-13′ supported the existence 
of a benzyldiformylphloroglucinol moiety (1a). The HSQC 
and 1H-1H COSY spectra (Figure 1) revealed the connections 
of C-3/C-2/C-1/C-10/C-9/C-8/C-7/C-11, C-12/C-11/C-13, and 
C-10/C-14, which were confirmed by HMBC correlations 
from H-12 to C-11, C-13, and C-7, H-7 to C-8 and C-9, H-14 
to C-9, C-10, and C-1, and H-3 to C-1 and C-2. Meanwhile, 
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C-5, and C-6 and H-15 to C-3, C-4, and C-5, revealed the  
C-linkages of C-3/C-4/C-5/C-6/C-7, C-1/C-6, and C-15/C-4. 
The above evidence strongly suggested that compound 1  
possessed a sesquiterpenoid moiety (1b) resembled scapanol.4 
Comparison of the 1H and 13C NMR data assigned to 1b with 
those of scapanol indicated that they were similar, except that 
Me-15 of scapanol was replaced by a methylene and a  
significant downfield shift (Δ ≈ 10.3 ppm) for C-4 of 1b was 
observed. The above observation implied that 1b was fused to 
1a via C-4 and C-15, which was further confirmed by the 
HMBC correlations from H-1′ to C-4 and C-15, as well as the 
degrees of unstauration requiring the existence of an ether 
bridge between C-4 and C-3′. 
The relative configuration of 1 was established by analysis 
of the ROESY data and proton coupling constants based on 
computer-generated 3D drawing with minimized energy by 
MM2 calculation using ChemBio3D software. In the ROESY 
spectrum, the pseudo-axially oriented proton H-3 at H 1.45 
(td, 13.3 and 3.4 Hz) in the half-chair cyclohexene ring B 
showed correlations with H-1 and Me-12, revealing the H-1 
and isopropyl group to be - and axially oriented. In addition, 
correlations between Me-14 and H-2α/H-8α suggested the  
Me-14 adopts another orientation. This deduction was further 
supported by the narrow half-peak width of H-10 (19.3 Hz), 
which suggested that in the chair cyclohexane ring A, the H-10 
was - and equatorially oriented and accordingly the Me-14 
was α- and axially oriented. The correlations among H-15, 
Me-12, and H-3 indicated the -orientation of the methylene 
at C-4. The -orientation of the phenyl was strongly suggested 
by the significant correlation of H-1′↔H-3, as also supported 
by the large coupling constant (J1′-15 = 10.5 Hz) which  
indicated a trans pseudo-diaxial relationship for H-1′ and  
H-15 in the half-chair dihydropyran ring. Therefore, these 
analyses established the relative configuration and the  
conformation of the A–B–C ring to be chair–half-chair–half-
chair, as shown in Figure 2. 
Guajadial D (2) was isolated as amorphous powder, [α]24D   + 
45.4 (c 0.20, CHCl3). Its molecular formula of C30H34O5 can 
be deduced by HREIMS spectrum, [M]+ peak at m/z 474.2410 
(calcd 474.2406). The UV spectrum (MeOH) showed  
absorptions at max 278 and 337 (sh) nm. The NMR spectra 
also displayed resonances for benzyldiformylphloroglucinol 
and scapanol moieties (Table 1). The HMBC correlations from 
H-7 to C-1/C-5/C-6, Me-14 to C-1/C-9/C-10, and H-15 to  
C-3/C-4/C-5, and comparison with 1H and 13C NMR  
spectroscopic data of 1, are in agreement with a meroterpenoid 
possessing the same planar structure as 1. Detailed analysis of 
its ROESY correlations (Figure 2), among which H-1↔H-11, 
Me-14↔H-2α/H-8α, and H-15α↔Me-12/H-5 established the 
relative configuration of the sesquiterpenoid unit identical to 
that of 1, however, revealed as a major difference from 1, the 
discrepant orientation of phenyl. The significant ROESY  
correlations between H-1′ and H-3 fixing the phenyl of 1 as 
-oriented was no longer observable in the ROESY spectrum 
of 2, instead, strong correlation between H-1′ and H-5 was 
observed, indicating the -orientation of phenyl. Consequently, 
the relative configuration of 2 was determined as shown in 
Figure 2. 
Guajadial E (3) was obtained as amorphous powder, [α]24D   + 
Table 1. 1H and 13C NMR dataa for 1 and 2 in CDCl3 
 1 2 
no. H (J in Hz) C H (J in Hz) C 
1 2.27 (m) 37.6 2.25 (m) 37.3 
2 1.65 (m) 21.9 1.79 (m) 22.0 
2 1.56 (m)  1.56 (m)  
3 2.07 (m) 30.8 1.90 (ddd, 13.2, 5.6, 4.0) 34.3 
3 1.45 (td, 13.3, 3.4)  1.34 (m)  
4  78.0  77.9 
5 5.33 (s) 125.4 5.59 (s) 123.0 
6  147.9  148.2 
7 1.57 (m) 50.6 1.62 (m) 50.9 
8 1.68 (m) 22.1 1.64 (m) 22.2 
8 1.65 (m)  1.63 (m)  
9 1.39 (br. d, 13.4) 28.7 1.36 (br. d, 13.2) 28.7 
9 1.81 (m)  1.80 (m)  
10 1.98 (m) 33.0 1.97 (m) 33.5 
11 1.76 (m) 26.9 1.82 (m) 26.9 
12 0.57 (d, 6.6) 21.5 0.75 (d, 6.6) 21.6 
13 0.88 (d, 6.5) 21.2 0.93 (d, 6.5) 21.3 
14 0.90 (d, 6.9) 14.3 0.87 (d, 7.0) 14.3 
15 2.04 (dd, 14.3, 10.5) 43.7 2.25 (dd, 14.2, 7.3) 43.2 
15 2.16 (dd, 14.3, 7.1)  2.02 (dd, 14.2, 9.3)  
1′ 4.06 (dd, 10.5, 7.1) 34.6 4.19 (dd, 9.3, 7.3) 34.1 
2′  102.8  102.9 
3′  164.6  164.7 
4′  104.5  104.6 
5′  168.6  168.6 
6′  104.0  104.0
7′  169.8  169.7 
8′  144.7  144.5 
9′, 13′ 7.15 (d, 7.3) 126.7 7.15 (d, 7.2) 126.8 
10′, 12′ 7.29 (t, 7.5) 128.5 7.28 (t, 7.6) 128.5
11′ 7.21 (t, 7.4) 126.3 7.21 (t, 7.3) 126.2 
14′ 10.10 (s) 192.4 10.10 (s) 192.3 
15′ 10.12 (s) 191.6 10.13 (s) 191.6 
5′-OH 13.58 (s)  13.57 (s) 
7′-OH 13.17 (s)  13.21 (s)  
aAssignments based on HMBC, HSQC, 1H-1H COSY, and ROESY spectra. 
 
Figure 1.  Key 1H-1H COSY and HMBC correlations of 
1 and 3 
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91.1 (c 0.20, CHCl3). The molecular formula was assigned as 
C30H34O5 by HREIMS at m/z 474.2399 [M]+ (calcd 474.2406). 
The UV spectrum (MeOH) showed absorptions at max 277 
and 337 (sh) nm. The NMR spectra (Table 2) also displayed 
signals for partial structure of benzyldiformylphloroglucinol 
(3a) besides which there were signals for four methyls, three 
methylenes, five methines, one oxygenated quarternary carbon, 
and a trisubstituted double bond that could be ascribed to a 
sesquiterpenoid unit with the aid of HSQC, 1H-1H COSY, and 
HMBC experiments (Figure 1). The HSQC and 1H-1H COSY 
spectra revealed the connections of C-1′/C-3/C-2/C-1/C-10/C-
9/C-8/C-7/C-11, C-12/C-11/C-13, and C-10/C-14. In the 
HMBC spectrum, cross peaks from H-7 to C-1, C-5, and C-6 
and Me-15 to C-3, C-4, and C-5 established the C-linkage of  
C-3/C-4/C-5/C-6/C-7, C-1/C-6, and C-15/C-4. The above  
evidence allowed the construction of a basic structural unit of 
a sesquiterpenoid 3b, to which signals assigned were  
analogous to those of 1b. Different from 1b, the C-3  
methylene was replaced by a methine, meanwhile, the C-15 
methylene was changed into a methyl group, suggesting a  
dihydropyran ring was fused to 3b via C-3 and C-4 instead of 
C-4 and C-15. The linkage between fragments 3a and 3b was 
further supported by HMBC experiment and molecular formula
information. In the HMBC spectrum, correlations of H-1′ with 
C-2, C-3, and C-4 revealed the connection of C-1′/C-3.  
According to the molecular formula information, the oxygen 
atom leftover was to bridge C-4 and C-3′, to form a  
dihydropyran ring. 
The relative configuration for 3 could be deduced by its 
ROESY spectrum. The ROESY correlations of H-1↔H-11, 
Me-14↔H-2α/H-8α, Me-15↔H-3, and H-1′↔H-1/Me-12/H-
2 established the relative configuration of 3 as shown in  
Figure 2. 
Guajadial F (4) was obtained as amorphous powder, [α]24D   + 
191.3 (c 0.21, CHCl3). The [M]+ at m/z 474.2410 (calcd 
474.2406) in its HREIMS gave a molecular formula C30H34O5. 
The UV spectrum (MeOH) showed absorptions at max 278 
and 342 nm. Careful comparison of its 1H and 13C NMR data 
(Table 2) with those of 3 suggested that they also share the 
same planar structure, which was further confirmed by HMBC 
correlations from H-7 to C-1/C-5/C-6, Me-15 to C-3/C-4/C-5, 
Me-14 to C-9/C-10/C-1, and H-1′ to C-2/C-3/C-3′/C-7′/C-9′/C-
13′. In the ROESY spectrum (Figure 2), correlations of H-
1↔H-11, Me-14↔H-3/8α, and Me-15↔H-3 established the 
relative configuration of the sesquiterpenoid moiety which was 
identical to that of 3. Meanwhile, the correlation of H-1′↔Me-
15 implied that 4 was a C-1′ epimer of 3. The noticeable  
difference between the chemical shift value of H-2α (3: δH 
1.65; 4: δH 0.58) also provided evidence that the phenyl had a 
different orientation because the significant up field shift (Δ ≈ 
1.07 ppm) can be explained by the anisotropic effect of phenyl 
 
Figure 2.  Key ROESY correlations of 1–4 
Table 2. 1H and 13C NMR dataa for 3 and 4 in CDCl3 
 3  4 
no. H (J in Hz) C H (J in Hz) C 
1 2.63 (m) 34.1 2.30 (br. t, 6.7) 35.1
2 1.65 (m) 27.0 0.58 (dd, 14.3, 3.9) 25.9
2 1.77 (m)  1.43 (ddd, 14.3, 14.3, 8.4)  
3 2.19 (m) 44.4 2.15 (ddd, 14.3, 7.1, 3.9) 38.1
4  80.0  78.0
5 5.31 (s) 126.7 5.59 (d, 1.4) 125.7
6  144.5  147.2
7 1.58 (m) 50.8 1.72 (m) 51.0
8 1.63 (m) 22.6 1.56 (m) 22.8
8 1.68 (m)  1.65 (m)  
9 1.40 (br. d, 13.4) 29.0 1.16 (br. d, 13.6) 28.8
9 1.85 (m)  1.73 (m)  
10 2.00 (m) 33.7 1.64 (m) 36.7
11 1.82 (m) 26.4 1.81 (m) 26.3
12 0.52 (d, 6.5) 21.1 0.78 (d, 6.5) 21.4
13 0.87 (d, 6.5) 21.1 0.91 (d, 6.4) 21.0
14 0.92 (d, 7.0) 14.3 0.65 (d, 7.1) 14.8
15 1.45 (s) 28.1 1.50 (s) 24.3
1′ 3.67 (d, 6.9) 38.6 4.41 (d, 7.1) 38.2
2′  104.3  100.5
3′  163.4  164.2
4′ 104.0  104.4
5′  168.2  168.5
6′  104.0  104.1
7′  169.7  170.3
8′ 144.5  140.7
9′ 7.14 (d, 7.2) 127.6 6.81 (m) 127.6
10′ 7.27 (t, 7.5) 128.3 6.70–7.45 (m) 127.6b
11′ 7.20 (t, 7.3) 126.2 7.23 (t, 6.9) 126.2
12′ 7.27 (t, 7.5) 128.3 6.70–7.45 (m) 128.5b
13′ 7.14 (d, 7.2) 127.6 6.70–7.45 (m) 127.6b
14′ 10.14 (s) 192.4 10.02 (s) 192.5
15′ 10.09 (s) 191.6 10.13 (s) 191.5
5′-OH 13.50 (s)  13.51 (s)  
7′-OH 13.05 (s)  13.31 (s)  
aAssignments based on HMBC, HSQC, 1H–1H COSY, and ROESY spectra. 
bInterchangable signals. 
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as shown in the computer-generated 3D drawing. Thus, the  
relative configuration of 4 was elucidated as shown in Figure 2. 
Because the key intermediate 3,5-dimethyl-2,4,6-trihydroxy-
benzophenon had been previously isolated from the same 
plant,5 the plausible biogenetic route of 1–4 could be proposed 
as shown in Scheme 1. The intermediate could be oxidized and 
then generated carbocation A, then A could attack 5 and 6 to 
generate tertiary carbocations B–E with resonance stabilization.
Further cyclization of B–E could construct compounds 1–4. 
Compounds 1–4 were evaluated for their in vitro growth  
inhibitory effects against five human cancer cell lines (MCF-7, 
A-549, SMMC-7721, SW480, and HL-60). All of the  
compounds exhibited positive activity (IC50 5.59–40.0 μM) 
toward all five human cancer cell lines except that compound 
1 was inactive to MCF-7 (Table 3). 
 
Experimental Section 
General Experimental Procedures. Optical rotations were 
measured on a Jasco P-1020 automatic digital polarimeter. IR 
spectra were obtained using a Bruker Tensor 27 FT-IR  
spectrometer with KBr pellets. NMR spectra were acquired 
with an Avance III 600 instrument at room temperature. EIMS 
(including HREIMS) were measured on VG-Auto-Spec-3000 
spectrometers. Silica gel (200–300 mesh, Qingdao Marine 
Chemical Inc., China) and Sephadex LH-20 (Amersham  
Biosciences, Sweden) were used for column chromatography. 
Fractions were monitored by TLC (Qingdao Marine Chemical 
 
Scheme 1.  Plausible biosynthetic pathway for 1–4
Table 3. Cytotoxicity data of compounds 1–4 with IC50 values 
(M) 
 Cell line 
compound MCF-7 A-549 SMMC-7721 SW480 HL-60 
1 > 40.00 24.96 19.37 27.65 19.39 
2 40.00 38.08 27.47 34.41 22.51 
3 7.78 6.30 5.59 13.39 7.77 
4 16.59 14.16 13.31 15.10 12.84 
cisplatina 13.42 8.55 5.58 12.10 1.24 
aCisplatin was used as positive control. 
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Inc., China) in combination with reversed-phase HPLC  
(Agilent 1100, Extend-C18 column, 5 μm, 4.6 × 150 mm). 
Prep. HPLC was performed using an Agilent 1100 series 
(ZORBAX SB-C18 column, 5 μm, 21.2 × 150 mm for 20 
mL/min). Silica gel for prep. TLC was obtained from Qingdao 
Marine Chemical Inc., China. 
 
Plant Material. Leaves of P. guajava were collected from 
south of Vietnam in 2009 and were identified by Prof. Yu 
Chen of Kunming Institute of Botany, Chinese Academy 
of Sciences. The voucher specimen was deposited at BioBioPha
Co., Ltd. 
 
Extraction and Isolation. Leaves of P. guajava (15 kg) 
were extracted with MeOH at room temperature. After  
filtration, the methanolic extract was evaporated under reduced 
pressure to get a residue (ca. 1400 g), which was fractionized 
by silica gel column chromatography using petroleum ether 
containing an increasing amount of acetone. Seperation of 2.5 
g of the fraction eluted with petroleum ether–acetone (200:1) 
by Sephadex LH-20 (CHCl3–MeOH, 1:1) and prep. HPLC on 
a ZORBAX SB-C18 column (84% CH3CN in H2O and 0.1% 
formic acid over 17 min followed by 84%→100% CH3CN in 
H2O and 0.1% formic acid to 24 min, 20 mL/min, 280 nm) 
yielded four fractions A–D. Fraction C (22 mg, tR = 
13.5→14.5 min) was further purified by prep. TLC (petroleum 
ether/EtOAc/formic acid, 50:2:0.1) to give 3 (7 mg, Rf ≈ 0.6). 
Fraction D (50 mg, tR = 17.1→19.1 min) was purified further 
by prep. HPLC on a ZORBAX SB-C18 column (90%→92% 
CH3CN in H2O and 0.1% formic acid over 12 min followed by 
92%→100% CH3CN in H2O and 0.1% formic acid to 15 min, 
20 mL/min, 280 nm) and then prep. TLC (petroleum 
ether/EtOAc/formic acid, 50:2:0.1) to afford 1 (8 mg, tR = 12.5 
min, Rf ≈ 0.5), 2 (8 mg, tR = 12.5 min, Rf ≈ 0.6), and 4 (7 mg, 
tR = 10.2 min, Rf ≈ 0.5). 
 
Guajadial C (1): amorphous powder; [α]24D   + 93.5 (c 0.20, 
CHCl3); UV (MeOH) max: 278, 337 (sh) nm; IR (KBr) max 
3441, 2956, 2926, 2870, 1633, 1440, 1383, 1302, 1266, 1230, 
1211, 1059, 848, 829 cm–1; 1H and 13C NMR data see Table 1; 
EIMS: m/z 474 [M]+ (100), 431 (64), 327 (23), 283 (20), 271 
(27), 195 (22), 161 (32), 119 (10), 105 (14), 91 (16); HREIMS: 
m/z 474.2401 (calcd 474.2406). 
 
Guajadial D (2): amorphous powder; [α]24D   + 45.4 (c 0.20, 
CHCl3); UV (MeOH) max: 278, 337 (sh) nm; IR (KBr) max 
3442, 2956, 2927, 2870, 1634, 1440, 1383, 1367, 1302, 1183, 
1156, 1125, 1098, 849, 762 cm–1; 1H and 13C NMR data see 
Table 1; EIMS: m/z 474 [M]+ (100), 431 (61), 327 (29), 283 
(20), 271 (24), 195 (11), 161 (12), 119 (4), 105 (6), 91 (5); 
HREIMS: m/z 474.2410 (calcd 474.2406). 
 
Guajadial E (3): amorphous powder; [α]24D   + 91.1 (c 0.20, 
CHCl3); UV (MeOH) max: 277, 337 (sh) nm; IR (KBr) max 
3440, 2958, 2927, 2872, 1632, 1439, 1383, 1305, 1194, 1180, 
1158, 1144, 1077, 699, 608 cm–1; 1H and 13C NMR data see 
Table 2; EIMS: m/z 474 [M]+ (71), 431 (18), 292 (60), 272 
(99), 244 (55), 204 (60), 161 (100), 119 (69), 105 (66), 91 (31), 
81 (26), 69 (15), 55 (20); HREIMS: m/z 474.2399 (calcd 
474.2406). 
 
Guajadial F (4): amorphous powder; [α]24D   + 191.3 (c 0.21, 
CHCl3); UV (MeOH) max: 278, 342 nm; IR (KBr) max 3424, 
2957, 2930, 2869, 1635, 1439, 1382, 1301, 1266, 1238, 1187, 
1154, 1134, 1090, 846, 775 cm–1; 1H and 13C NMR data see 
Table 2; EIMS: m/z 474 [M]+ (25), 431 (11), 272 (100), 244 
(50), 204 (54), 161 (85), 119 (81), 105 (68), 91 (49), 81 (28), 
69 (14), 55 (10); HREIMS: m/z 474.2410 (calcd 474.2406). 
 
Cytotoxicity Bioassays. The following human tumor cell 
lines were used: HL-60, SMMC-7721, A-549, MCF-7, and 
SW480. All cells were cultured in RPMI-1640 or DMEM  
medium (Hyclone, Logan, UT), supplemented with 10% fetal 
bovine serum (Hyclone) at 37 °C in a humidified atmosphere 
with 5% CO2. The cytotoxicity assay was performed according 
to an MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-
phenyl)-2-(4-sulfopheny)-2H-tetrazolium) method6 with minor 
modifications. Briefly, 100 μL of adherent cells were seeded 
into each well of a 96-well cell culture plate and allowed to 
adhere for 12 h before drug addition, while suspended cells 
were seeded just before drug addition, both with an initial 
density of 1 × 105 cells/mL in 100 μL medium. Each cell line 
was exposed to the test compound at various concentrations in 
triplicate for 48 h, with cisplatin (Sigma) as positive control. 
After the incubation, 20 μL MTS and 100 μL medium was 
added to each well after removal of 100 L medium, and the 
incubation continued for 4 h at 37 °C. The optical density of 
the lysate was measured at 490 nm in a 96-well microtiter 
plate reader (Bio-Rad 680). The IC50 value of each compound 
was calculated by the Reed and Muench’s method.7 
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